COMMUNIQUÉ DE PRESSE publié le 23/01/2024 à 11:22, il y a 2 années 7 mois Adler Group S.A. continues on its restructuring path as planned Adler Group S.A. announces that it will continue its planned restructuring path despite the decision of the Court of Appeal to set aside the Sanction Order, emphasizing that the amendments to the bond terms remain valid under German law. The company expresses gratitude to its stakeholders for their support during this process. Adler Group S.A. Restructuring Path Sanction Order Bond Terms Court Of Appeal
COMMUNIQUÉ DE PRESSE publié le 28/11/2023 à 07:00, il y a 2 années 9 mois EQS-News: Adler Group S.A. reduces debt thanks to successful portfolio sales in difficult market environment
COMMUNIQUÉ DE PRESSE publié le 19/10/2023 à 09:13, il y a 2 années 11 mois Adler Group S.A.: Successful squeeze-out at ADLER Real Estate AG
COMMUNIQUÉ DE PRESSE publié le 16/10/2023 à 18:21, il y a 2 années 11 mois Adler Group S.A. initiates appointment of auditor
COMMUNIQUÉ DE PRESSE publié le 16/10/2023 à 18:19, il y a 2 années 11 mois EQS-Adhoc: Adler Group S.A.: Auditor firm declares willingness to audit the standalone and consolidated fi-nancial statements of Adler Group S.A. for the fiscal year 2022
COMMUNIQUÉ DE PRESSE publié le 09/10/2023 à 18:35, il y a 2 années 11 mois Adler Group S.A. announces the results of its tender offer for its outstanding EUR 165,000,000 senior secured convertible notes due 2023
COMMUNIQUÉ DE PRESSE publié le 04/10/2023 à 19:39, il y a 2 années 11 mois Adler Group announces expected closing date of New Notes and advanced and constructive discussions with potential auditors
COMMUNIQUÉ DE PRESSE publié le 04/10/2023 à 19:29, il y a 2 années 11 mois EQS-Adhoc: Adler Group S.A. is in advanced and constructive discussions with potential auditors
COMMUNIQUÉ DE PRESSE publié le 29/09/2023 à 14:29, il y a 2 années 11 mois Adler Group S.A. successfully places EUR 191,000,000 senior secured notes due 2025
COMMUNIQUÉ DE PRESSE publié le 18/09/2023 à 08:38, il y a 3 années Adler Group S.A. to extend its tender offer for its outstanding secured convertible notes
Publié le 21/09/2026 à 18:19, il y a 12 minutes Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 14 au 18 septembre 2026
Publié le 21/09/2026 à 18:19, il y a 12 minutes Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Publié le 21/09/2026 à 18:01, il y a 29 minutes Partnership agreement signed between Manitou Group and HD Construction Equipment
Publié le 21/09/2026 à 17:46, il y a 45 minutes WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Publié le 21/09/2026 à 17:46, il y a 45 minutes WEB SA - RESULTATS SEMESTRIELS STATUTAIRES AU 30/06/2026
Publié le 21/09/2026 à 15:45, il y a 2 heures 46 minutes Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Publié le 21/09/2026 à 14:20, il y a 4 heures 11 minutes Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Publié le 21/09/2026 à 14:05, il y a 4 heures 26 minutes Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Publié le 21/09/2026 à 14:00, il y a 4 heures 31 minutes Dateline Files Motion to Resume Operations at Colosseum
Publié le 21/09/2026 à 13:45, il y a 4 heures 46 minutes Nine Mile Metals DDH WD-26-11 Intersects 2 High Grade VMS Zones Over 27.6M Including 3.08% CU-EQ Over 10.70M, 3.27% CU-EQ Over 9.30M and 4.30% CU-EQ Over 5.0M
Publié le 21/09/2026 à 17:45, il y a 46 minutes EQS-Adhoc: Airbus reports share buyback transactions 11-18 September 2026
Publié le 21/09/2026 à 17:45, il y a 46 minutes Charwood Energy poursuit sur un rythme de croissance élevé. Chiffre d’affaires semestriel en hausse de +43 % à 5,6 M€.
Publié le 21/09/2026 à 17:45, il y a 46 minutes Charwood Energy continues to grow at a strong pace. H1 revenue up +43% to €5.6m.
Publié le 21/09/2026 à 17:00, il y a 1 heure 31 minutes Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)